Skip to content

Nissen Sleeve by Single Port With Magnetic Assistance

Double Magnetic-assisted Single-port Nissen Sleeve

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04931706
Enrollment
300
Registered
2021-06-18
Start date
2021-06-05
Completion date
2023-12-05
Last updated
2021-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Candidate, GERD, Obesity

Keywords

Bariatric Surgery, Magnetic assisted, Singe port, Nissen Sleeve

Brief summary

New approach for Nissen Sleeve Gastrectomy by single port using double magnetic system

Detailed description

A bariatric surgery is performed for weight loss and esophagogastric reflux, called Nissen Sleeve, in which a new approach is used which is the only port that helps to shorten the hospital stay because it decreases postoperative pain as well as increases the esthetic Ad benefit. In addition, a system of magnets is used to assist in different steps of the surgery for the correct retraction of the tissues and to be able to suture or perform the correct dissection.

Interventions

OTHERMagnetics Assisted by Singe port

Use of magnet for assistance through the surgery, and a novel approach as it is single port

Sponsors

Unidad Internacional de Cirugia Bariatrica y Metabolica
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Any patient with controlled comorbidities suffering from obesity and GERD.

Exclusion criteria

* Patients with pacemakers, psychiatric problems or uncontrolled metabolic diseases

Design outcomes

Primary

MeasureTime frameDescription
Surgical Complications1 monthany adverse event during the surgery
Surgical time30 minuteshow long does the surgery take
Weight loss follow up1 monthKg that the patient loss

Countries

Venezuela

Contacts

Primary ContactGuillermo Borjas, M.D.
MaldonadoAndres94@gmail.com4146863041

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026